CoChat
Sign Up
Cited by 7,094Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionInsurance, Mortality, Demography, Risk Management

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Rahib, Lola, Smith, Benjamin D., Aizenberg, Rhonda, Rosenzweig, Allison B., Fleshman, Julie M., Matrisian, Lynn M.·2014·Cancer Research
DOI 10.1158/0008-5472.can-14-0155
Open this paper in CoChat — free account

Abstract

Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the average annual percentage changes in incidence and death rates. Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, respectively. Lung cancer is projected to remain the top cancer killer throughout this time period. However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, respectively. Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-0155

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 18

  1. Siegel, 2014, Cancer Statistics, 2014, CA Cancer J Clin, 64, 9, 10.3322/caac.21208 · DOI · Paper page
  2. Smith, 2009, Future of cancer incidence in the United States: burdens upon an aging, changing nation, J Clin Oncol, 27, 2758, 10.1200/JCO.2008.20.8983 · DOI
  3. Jemal, 2013, Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels, J Natl Cancer Inst, 105, 175, 10.1093/jnci/djs491 · DOI
  4. Edwards, 2013 16, Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer, Cancer
  5. Matrisian, 2012, The alarming rise of pancreatic cancer deaths in the United States: why we need to stem the tide today
  6. Zauber, 2008, Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force, Ann Intern Med, 149, 659, 10.7326/0003-4819-149-9-200811040-00244 · DOI
  7. Mandel, 2000, The effect of fecal occult-blood screening on the incidence of colorectal cancer, N Engl J Med, 343, 1603, 10.1056/NEJM200011303432203 · DOI
  8. Edwards, 2010, Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates, Cancer, 116, 544, 10.1002/cncr.24760 · DOI · Paper page
  9. Davies, 2014 20, Current thyroid cancer trends in the United States, JAMA Otolaryngol Head Neck Surg, 10.1001/jamaoto.2014.1 · DOI
  10. Heller, 2007, Do all cancers need to be treated? the role of thyroglobulin in the management of thyroid cancer: The 2006 hayes martin lecture, Arch Otolaryngol Head Neck Surg, 133, 639, 10.1001/archotol.133.7.639 · DOI
  11. Welch, 2010, Overdiagnosis in Cancer, J Natl Cancer Inst, 102, 605, 10.1093/jnci/djq099 · DOI
  12. Bosch, 2004, Primary liver cancer: worldwide incidence and trends, Gastroenterology, 127, S5, 10.1053/j.gastro.2004.09.011 · DOI
  13. Bruix, 2011, American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update, Hepatology, 53, 1020, 10.1002/hep.24199 · DOI
  14. Spanknebel, 2001, Advances in the surgical management of pancreatic cancer, Cancer J, 7, 312
  15. Ma, 2013, Pancreatic cancer death rates by race among US men and women, 1970–2009, J Natl Cancer Inst, 105, 1694, 10.1093/jnci/djt292 · DOI
  16. Srivastava, 2008, Translational Research Working Group developmental pathway for biospecimen-based assessment modalities, Clin Cancer Res, 14, 5672, 10.1158/1078-0432.CCR-08-1267 · DOI
  17. Kaitin, 2010, Deconstructing the drug development process: the new face of innovation, Clin Pharmacol Ther, 87, 356, 10.1038/clpt.2009.293 · DOI
  18. Scientific framework for recalcitrant cancers 2013

Cited by

Sorted by citations

Items 101–127 of 127

Metadata

Authors
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M.
Affiliations
The University of Texas MD Anderson Cancer Center (US)
ORCID
Venue
Cancer Research
Publisher
American Association for Cancer Research (AACR)
Published
2014-05-29
Volume
74
Issue
11
Pages
2913-2921
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
DOI
10.1158/0008-5472.can-14-0155
OpenAlex
W1968812902
Cited by
7,094
References
1
Citations by year
2026: 307 · 2025: 502 · 2024: 616 · 2023: 774 · 2022: 820 · 2021: 914 · 2020: 883 · 2019: 715 · 2018: 565 · 2017: 421 · 2016: 341 · 2015: 187 · 2014: 39
FWCI
158.94
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
  • Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
Keywords
cancer incidence projections, cancer mortality projections, thyroid cancer, liver cancer, pancreatic cancer, lung cancer, breast cancer, prostate cancer, colorectal cancer, melanoma, uterine cancer, cancer burden, United States
MeSH terms
Age Factors, Female, Forecasting, Humans, Lung Neoplasms, Male, Mortality, Pancreatic Neoplasms, Thyroid Neoplasms, United States, Models, Statistical, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review